Inhibition of the cerebral renin-angiotensin system to limit cognitive decline in elderly hypertensive persons

Cardiovascular Drugs and Therapy

Volumn 25, Issue 4, 2011, Pages 277-279

  Opie, Lionel H ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Brain; Cognition; Memory; Renin angiotensin

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENAZEPRIL; CANDESARTAN; CAPTOPRIL; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; HYDROCHLOROTHIAZIDE; LISINOPRIL; LOSARTAN; MOEXIPRIL; PERINDOPRIL; PROPRANOLOL; QUINAPRIL; RAMIPRIL; RENIN ANGIOTENSIN SYSTEM INHIBITOR; TELMISARTAN; TRANDOLAPRIL; UNCLASSIFIED DRUG;

AGED; AGING; COGNITIVE DECLINE; DIABETIC MICROANGIOPATHY; DISORDERS OF HIGHER CEREBRAL FUNCTION; DRUG MEGADOSE; DRUG PENETRATION; HEART FAILURE; HEART PROTECTION; HUMAN; HYPERTENSION; LIFE EXPECTANCY; LONGEVITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SOCIAL STATUS;

AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; BLOOD-BRAIN BARRIER; BRAIN; COGNITION DISORDERS; HUMANS; HYPERTENSION;

EID: 80052283951     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-011-6316-6     Document Type: Review

References (17)

1. GS Zubenko RA Nixon 1984 Mood-elevating effect of captopril in depressed patients Am J Psychiatry 141 110 111 6318579 1:STN:280:DyaL2c7gtFynsg%3D%3D (Pubitemid 14218177)
2. SH Croog S Levine MA Testa B Brown CJ Bulpitt CD Jenkins, et al. 1986 The effects of antihypertensive therapy on the quality of life N Engl J Med 314 1657 1664 3520318 10.1056/NEJM198606263142602 1:STN:280:DyaL283jtVOnsA%3D%3D (Pubitemid 16097842)
3. JM Barnes NM Barnes B Costall ZP Horovitz RJ Naylor 1989 Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro Brain Res 491 1 136 143 2765877 10.1016/0006-8993(89)90095-4 1:CAS:528:DyaL1MXkvFWiurw%3D (Pubitemid 19159084)
4. NH Greig T Utsuki DK Ingram Y Wang G Pepeu C Scali, et al. 2005 Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent Proc Natl Acad Sci U S A 102 17213 17218 16275899 10.1073/pnas.0508575102 1:CAS:528: DC%2BD2MXht1yksLfE (Pubitemid 41692709)
5. RC Petersen RG Thomas M Grundman D Bennett R Doody S Ferris Alzheimer's Disease Cooperative Study Group, et al. 2005 Vitamin E and donepezil for the treatment of mild cognitive impairment N Engl J Med 352 2379 2388 15829527 10.1056/NEJMoa050151 1:CAS:528:DC%2BD2MXltVCjsbg%3D
6. L Danielyan R Klein LR Hanson M Buadze M Schwab CH Gleiter, et al. 2010 Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease Rejuvenation Res 13 2-3 195 201 20370487 10.1089/rej.2009.0944 1:CAS:528:DC%2BC3cXlvFyksbk%3D
7. K Washida M Ihara K Nishio Y Fujita T Maki M Yamada, et al. 2010 Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion Stroke 41 8 1798 1806 20595663 10.1161/STROKEAHA.110.583948 1:CAS:528:DC%2BC3cXpsVCmt7Y%3D
8. R Fogari A Mugellini A Zoppi G Derosa C Pasotti E Fogari, et al. 2003 Influence of losartan and atenolol on memory function in very elderly hypertensive patients J Hum Hypertens 17 781 785 14578918 10.1038/sj.jhh.1001613 1:CAS:528:DC%2BD3sXosVSgsr4%3D (Pubitemid 37441435)
9. BK Saxby F Harrington KA Wesnes IG McKeith GA Ford 2008 Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial Neurology 70 1858 1866 18458219 10.1212/01.wnl.0000311447.85948.78 1:CAS:528:DC%2BD1cXhtFagsbzJ (Pubitemid 351653953)
10. T Ohrui N Tomita T Sato-Nakagawa T Matsui M Maruyama K Niwa, et al. 2004 Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression Neurology 63 7 1324 1325 15477567 1:STN:280:DC%2BD2crgvVWmug%3D%3D (Pubitemid 39350046)
11. KM Sink X Leng J Williamson SB Kritchevsky K Yaffe L Kuller, et al. 2009 Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study Arch Intern Med 169 13 1195 1202 19597068 10.1001/archinternmed.2009.175 1:CAS:528: DC%2BD1MXptlWksbc%3D
12. K Yamada S Uchida S Takahashi M Takayama Y Nagata N Suzuki, et al. 2010 Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease Brain Res 1352 176 186 20627092 10.1016/j.brainres.2010.07.006 1:CAS:528:DC%2BC3cXhtVKisLvM
13. Dong YF, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K, et al. Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease. FASEB J. 2011 May 18. [Epub ahead of print]
14. N-C Li A Lee RA Whitmer M Kivipelto E Lawler LE Kazis, et al. 2010 Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis BMJ 340 b5465 20068258 10.1136/bmj.b5465
15. M Nagai S Hoshide K Kario 2010 Hypertension and dementia Am J Hypertens 23 116 124 19927134 10.1038/ajh.2009.212
16. C Tzourio C Anderson N Chapman M Woodward B Neal S MacMahon, et al. 2003 Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease Arch Intern Med 163 1069 1075 12742805 10.1001/archinte.163.9.1069 1:CAS:528:DC%2BD3sXkt1altrc%3D (Pubitemid 36548935)
17. I Hajjar M Hart W Milberg V Novak L Lipsitz 2009 The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: role of the renin angiotensin system inhibition BMC Geriatr 9 48 19922631 10.1186/1471-2318-9-48